SITC Cancer Immunotherapy CONNECT


SITC Sparkathon Applications Accepted Now Through June 15

The SITC Sparkathon is an exciting opportunity for early career professionals interested in solving hurdles facing the cancer immunotherapy field. Ignite innovation – apply to participate in the SITC Sparkathon today!

Learn More


Explore the new SITC Cancer Immunotherapy connectED

SITC connectED is the new adaptive learning portal connecting users to online educational activities about cancer immunotherapy with opportunities for continuing education credits.

Explore SITC connectED


Register now for the 32nd Annual Meeting & Pre-Conference Programs

Visit the SITC 2017 Annual Meeting website for the latest information on the premier destination for scientific exchange, education and networking in the cancer immunotherapy field.


Non-Small Cell Lung Cancer Immunotherapy: Clinical Management

Complete this FREE online CME/CNE activity to learn more about immunotherapy for non-small cell lung cancer, then engage your patients in discussion today!

*Current as of August 2016

Earn Your Credit

2017 Advances in Cancer Immunotherapy™ – Los Angeles

Learn basic immunology principles, the mechanisms and clinical applications of immunotherapy for disease states with FDA-approved treatments and so much more. Join us June 29 in Los Angeles for our Advances in Cancer Immunotherapy™ program, SITC's regional cancer immunotherapy education series.



Join the Discussion – Create a SITC Cancer Immunotherapy CONNECT Account

Learn and share information in the new SITC Cancer Immunotherapy CONNECT Open Forum! Follow a few easy steps to create a free SITC CONNECT account, upload a profile photo and join the conversation.



FOCIS-SITC Cancer Immunity & Immunotherapy Course

June 14 • Hilton Chicago • Chicago, Illinois

This course will review tumor immunology as the foundation of cancer immunotherapy, emphasizing fundamental principles, recent clinical advances, current limitations and opportunities for furthering clinical progress.

Learn More


Explore resources and educational opportunities for cancer patients and those who advocate for them.







Track the latest advancements and educational opportunities in cancer immunotherapy and immunology.







Advance science, submit your manuscript and monitor the global progress of cancer immunotherapy research.






Latest Discussions

  • Hello! First off, we would like to thank each and every one of you who enlisted in the iPad giveaway onsite at ONS Congress. Our team got to meet some truly wonderful individuals at our exhibit booth with varying levels of knowledge regarding cancer ...

  • Hello, Now that 4 of the 5 immunotherapies for bladder cancer have received their FDA approval, what is the talk amongst your docs as to which will be the go-to and why? ------------------------------ Pam Profusek RN, MS Research Nurse Cleveland Clinic ...

  • Indian FDA after clinical trials for DC immunotherapy has approved post marketing surveillance to be conducted by Delhi based research Biotech company in collaboration with oncologists. The roll out across India should start by May end. The license is ...

Follow the SITC Twitter Feed.


Connect with colleagues at these Upcoming Events.


Ignite the Sparkathon

Donate today to support early career scientists who are emerging leaders seeking to advance research in the cancer immunotherapy field.


Learn More


Publications & Resources

Journal for ImmunoTherapy of Cancer

An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.

Learn More


Making Cure a Reality

It is the mission of the Society for Immunotherapy of Cancer to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.


Learn More